$ENTX 4 SEC Filings

Filed On	Filing
07 Aug 2026	Form 4: Ellis Sean, Director Received 20,034 shares as a grant or award · Granted 40,000 Stock Option (right to buy)
07 Aug 2026	Form 4: Rubin Steven D, Director Received 19,117 shares as a grant or award · Granted 76,773 Stock Option (right to buy)
07 Aug 2026	Form 4: Malca Yonatan, Director Received 22,815 shares as a grant or award
07 Aug 2026	Form 4: Taitel Haya, Director Received 20,790 shares as a grant or award
07 Aug 2026	Form 4: Yaacov-Garbeli Dana, Chief Financial Officer Granted 140,000 Stock Option (right to buy)
07 Aug 2026	Form 4: Galitzer Hillel, Chief Operating Officer Granted 200,000 Stock Option (right to buy)
07 Aug 2026	Form 4: Burshtein Gregory, Chief of R&D Granted 180,000 Stock Option (right to buy)
07 Aug 2026	Form 4: Toledano Miranda Jayne, Director Granted 700,000 Stock Option (right to buy)
07 Aug 2026	Form 4: Germano Geno J, Director Received 25,014 shares as a grant or award · Granted 93,014 Stock Option (right to buy)
16 Jul 2026	Form 4: Toledano Miranda Jayne, Director Received 420,560 shares as a grant or award
08 May 2026	Form 4: Burshtein Gregory, Chief of R&D Received 87,591 shares as a grant or award
08 May 2026	Form 4: Galitzer Hillel, Chief Operating Officer Received 72,993 shares as a grant or award
08 May 2026	Form 4: Yaacov-Garbeli Dana, Chief Financial Officer Received 58,394 shares as a grant or award
11 Mar 2026	Form 4: Germano Geno J, Director Bought 20,000 shares ($26K)
09 Mar 2026	Form 4: Ellis Sean, Director Bought 10,000 shares ($12.3K)
17 Feb 2026	Form 4: Rubin Steven D, Director Bought 5,000 shares ($7.45K)
11 Feb 2026	Form 4: Taitel Haya, Director Bought 7,500 shares ($11.1K)
11 Feb 2026	Form 4: Germano Geno J, Director Bought 20,000 shares ($29.8K)
11 Feb 2026	Form 4: Rubin Steven D, Director Bought 10,000 shares ($12K)
11 Feb 2026	Form 4: Ellis Sean, Director Bought 18,000 shares ($22.3K)

Comments